Inventor
BURKE PATRICK
US23 patents
⚠️ This page may combine multiple inventors who share the name “BURKE PATRICK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SEATTLE GENETICS INC
10 patentsUS9713647B2Jul 25, 2017
Pyrrolobenzodiazepines and targeted conjugates
SEATTLE GENETICS INC26 citations94
US9707301B2Jul 18, 2017
Pyrrolobenzodiazepines and targeted conjugates
SEATTLE GENETICS INC21 citations94
US9592240B2Mar 14, 2017
Targeted pyrrolobenzodiazapine conjugates
SEATTLE GENETICS INC23 citations94
US9387259B2Jul 12, 2016
Pyrrolobenzodiazepines and targeted conjugates
SEATTLE GENETICS INC24 citations94
US9526798B2Dec 27, 2016
Pyrrolobenzodiazepines and targeted conjugates
SEATTLE GENETICS INC21 citations92
US9587019B2Mar 7, 2017
CD33 antibodies and use of same to treat cancer
SEATTLE GENETICS INC7 citations82
US10561739B2Feb 18, 2020
Targeted pyrrolobenzodiazapine conjugates
SEATTLE GENETICS INC4 citations73
US10328084B2Jun 25, 2019
Pyrrolobenzodiazepines and targeted conjugates
SEATTLE GENETICS INC1 citations62
US10787514B2Sep 29, 2020
CD33 antibodies and use of same to treat cancer
SEATTLE GENETICS INC1 citations61
US10329352B2Jun 25, 2019
Pyrrolobenzodiazepines and targeted conjugates
SEATTLE GENETICS INC0 citations52
SEAGEN INC
4 patentsUS11103593B2Aug 31, 2021
Pegylated drug-linkers for improved ligand-drug conjugate pharmacokinetics
SEAGEN INC13 citations82
US11116847B2Sep 14, 2021
Methylene carbamate linkers for use with targeted-drug conjugates
SEAGEN INC3 citations71
US11819553B2Nov 21, 2023
Glypican 3 antibodies and conjugates thereof
SEAGEN INC1 citations59
US11938194B2Mar 26, 2024
Cysteine mutated antibodies for conjugation
SEAGEN INC0 citations51